Groove Botanicals 10-Q: $1,866 Cash, Going Concern, $15M Series C Planned
GRVE has more than doubled off its 52-week low of $0.001.
Summary
Groove Botanicals ended September with $1,866 of cash, a $1.6 million working capital deficit and a repeated going-concern warning, pinning survival on an uncommitted $15 million Series C preferred raise expected to become effective around December 30, 2026.
Key Events · Earnings and Guidance · GRVE
-
Going Concern Doubt Reaffirmed
A six-month net loss of $52,733 and an accumulated deficit of $35,716,936 as of September 30, 2026 — management states these factors raise substantial doubt about the ability to continue as a going concern.
-
Cash of $1,866, $1.6M Working Capital Hole
Cash stood at $1,866 against current liabilities of $1,636,978, leaving a working capital deficit of $1,618,216. Operating activities burned $50,636 in the six months, funded mainly by $38,500 of CEO advances plus a $12,500 third-party advance.
-
$15M Series C Still Uncommitted
The company intends to raise up to $15,000,000 through a new Series C Preferred Stock, but states it has no commitments from any investor and the series is not yet designated.
-
CEO Ends Salary, Forgives $12,000
Kent Rodriguez's employment contract was terminated effective June 30, 2026; he forgave $12,000 of accrued compensation as a capital contribution and continues as sole officer and director without salary.
Analysis · GRVE · Energy & Transportation
With $1,866 of cash against $1.64 million of current liabilities, the company is effectively out of money, and management repeats that substantial doubt exists about its ability to continue as a going concern. The only path it describes is a $15 million Series C preferred financing that has not been authorized yet (effective on or about December 30, 2026) and for which no investor has committed a dollar. Meanwhile the sole officer, Kent Rodriguez, terminated his own $4,000/month employment contract, forgave $12,000 of accrued pay as a capital contribution, and now works without salary — a cost cut that saves cash but also underscores how thin the operation is. The pivot to licensing Norwegian university technology is still just negotiation: no agreements, no identified IP, no revenue.
How filings like this one have moved
In the 30 days to Nov 11, 2026, 48.1% of the 1752 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GRVE was trading at $0.01 on OTC in the Energy & Transportation sector, with a market capitalization of approximately $360.8K. The 52-week trading range was $0.00 to $0.30. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.